214 related articles for article (PubMed ID: 18835580)
1. Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.
Garg A; Tisdale AW; Haidari E; Kokkoli E
Int J Pharm; 2009 Jan; 366(1-2):201-10. PubMed ID: 18835580
[TBL] [Abstract][Full Text] [Related]
2. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
Demirgöz D; Garg A; Kokkoli E
Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
[TBL] [Abstract][Full Text] [Related]
3. pH-Sensitive PEGylated liposomes functionalized with a fibronectin-mimetic peptide show enhanced intracellular delivery to colon cancer cell.
Garg A; Kokkoli E
Curr Pharm Biotechnol; 2011 Aug; 12(8):1135-43. PubMed ID: 21470144
[TBL] [Abstract][Full Text] [Related]
4. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
Shroff K; Kokkoli E
Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
[TBL] [Abstract][Full Text] [Related]
5. Effect of linker and spacer on the design of a fibronectin-mimetic peptide evaluated via cell studies and AFM adhesion forces.
Craig JA; Rexeisen EL; Mardilovich A; Shroff K; Kokkoli E
Langmuir; 2008 Sep; 24(18):10282-92. PubMed ID: 18693703
[TBL] [Abstract][Full Text] [Related]
6. Dual-ligand α
Levine RM; Kokkoli E
J Control Release; 2017 Apr; 251():24-36. PubMed ID: 28215671
[TBL] [Abstract][Full Text] [Related]
7. Transfection mechanisms of polyplexes, lipoplexes, and stealth liposomes in α₅β₁ integrin bearing DLD-1 colorectal cancer cells.
Adil MM; Erdman ZS; Kokkoli E
Langmuir; 2014 Apr; 30(13):3802-10. PubMed ID: 24635537
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
9. Binding of the fibronectin-mimetic peptide, PR_b, to alpha5beta1 on pig islet cells increases fibronectin production and facilitates internalization of PR_b functionalized liposomes.
Atchison NA; Fan W; Papas KK; Hering BJ; Tsapatsis M; Kokkoli E
Langmuir; 2010 Sep; 26(17):14081-8. PubMed ID: 20704278
[TBL] [Abstract][Full Text] [Related]
10. Development of High-Functionality and -Quality Lipids with RGD Peptide Ligands: Application for PEGylated Liposomes and Analysis of Intratumoral Distribution in a Murine Colon Cancer Model.
Suga T; Kato N; Hagimori M; Fuchigami Y; Kuroda N; Kodama Y; Sasaki H; Kawakami S
Mol Pharm; 2018 Oct; 15(10):4481-4490. PubMed ID: 30179010
[TBL] [Abstract][Full Text] [Related]
11. PR_b functionalized stealth liposomes for targeted delivery to metastatic colon cancer.
Adil M; Belur L; Pearce TR; Levine RM; Tisdale AW; Sorenson BS; McIvor RS; Kokkoli E
Biomater Sci; 2013 Apr; 1(4):393-401. PubMed ID: 32481904
[TBL] [Abstract][Full Text] [Related]
12. Enhanced integrin mediated signaling and cell cycle progression on fibronectin mimetic peptide amphiphile monolayers.
Shroff K; Pearce TR; Kokkoli E
Langmuir; 2012 Jan; 28(3):1858-65. PubMed ID: 22149259
[TBL] [Abstract][Full Text] [Related]
13. Peptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma.
Dai W; Yang T; Wang Y; Wang X; Wang J; Zhang X; Zhang Q
Nanomedicine; 2012 Oct; 8(7):1152-61. PubMed ID: 22306158
[TBL] [Abstract][Full Text] [Related]
14. Design of cyclic RKKH peptide-conjugated PEG liposomes targeting the integrin α₂β₁ receptor.
Knudsen NØ; Schiffelers RM; Jorgensen L; Hansen J; Frokjaer S; Foged C
Int J Pharm; 2012 May; 428(1-2):171-7. PubMed ID: 22414425
[TBL] [Abstract][Full Text] [Related]
15. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
[TBL] [Abstract][Full Text] [Related]
16. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
[TBL] [Abstract][Full Text] [Related]
17. Effect of PEG pairing on the efficiency of cancer-targeting liposomes.
Saw PE; Park J; Lee E; Ahn S; Lee J; Kim H; Kim J; Choi M; Farokhzad OC; Jon S
Theranostics; 2015; 5(7):746-54. PubMed ID: 25897339
[TBL] [Abstract][Full Text] [Related]
18. Increasing cancer-specific gene expression by targeting overexpressed α5β1 integrin and upregulated transcriptional activity of NF-κB.
Adil MM; Levine RM; Kokkoli E
Mol Pharm; 2014 Mar; 11(3):849-58. PubMed ID: 24483950
[TBL] [Abstract][Full Text] [Related]
19. Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy.
Corvo ML; Mendo AS; Figueiredo S; Gaspar R; Larguinho M; Guedes da Silva MF; Baptista PV; Fernandes AR
Pharm Res; 2016 Jun; 33(6):1351-8. PubMed ID: 27033349
[TBL] [Abstract][Full Text] [Related]
20. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.
Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
J Control Release; 2011 Jul; 153(2):141-8. PubMed ID: 21447361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
